医療ロボットの世界市場予測（～2021年）：手術ロボット、リハビリロボット、病院ロボット、非侵襲手術ロボット...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 17

2 RESEARCH METHODOLOGY 18
2.1 RESEARCH METHODOLOGY STEPS 18
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 19
2.2.1 SECONDARY RESEARCH 19
2.2.1.1 Key data from secondary sources 19
2.2.2 PRIMARY RESEARCH 20
2.2.2.1 Key data from primary sources 21
2.2.2.2 Key insights from primary sources 21
2.2.2.3 Key industry insights 22
2.3 MARKET SIZE ESTIMATION METHODOLOGY 22
2.4 MARKET DATA VALIDATION AND TRIANGULATION 25
2.5 ASSUMPTIONS FOR THE STUDY 26

3 EXECUTIVE SUMMARY 27

4 PREMIUM INSIGHTS 30
4.1 GLOBAL MEDICAL ROBOTS MARKET OVERVIEW 30
4.2 GEOGRAPHIC ANALYSIS: MEDICAL ROBOTS MARKET, BY TYPE OF SURGICAL ROBOTIC SYSTEM 30
4.3 GEOGRAPHICAL SNAPSHOT OF THE MEDICAL ROBOTS MARKET 31
4.4 MEDICAL ROBOTS MARKET, BY APPLICATION (2016) 31

5 MARKET OVERVIEW 32
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 33
5.2.1.1 Advantages offered by robot-assisted training in rehabilitation therapy 33
5.2.1.2 Technological advancements 34
5.2.1.3 Increase in funding for medical robots research 35
5.2.1.4 Issuance of IPOs by medical robots companies 35
5.2.1.5 Growing hospital investments in medical robots 36
5.2.2 RESTRAINTS 36
5.2.2.1 Safety concerns over robotic surgery devices 36
5.2.2.2 High cost of robotic systems and unjustified cost benefits of robotic surgeries 36
5.2.3 OPPORTUNITIES 37
5.2.3.1 Rapid growth in the aging population 37
5.2.3.2 Development of nanorobots for cancer treatment 37
5.2.3.3 Rising patient preference for minimally invasive surgeries 37

6 INDUSTRY INSIGHTS 39
6.1 REGULATORY ASSESSMENT 39
6.1.1 INTRODUCTION 39
6.1.2 U.S. 39
6.1.2.1 FDA Device Classification 39
6.1.3 EUROPE 40
6.1.3.1 Environmental protection agency (EPA) device classification 40
6.1.4 JAPAN 42
6.1.4.1 PMDA device classification 42
6.1.5 CHINA 44
6.1.5.1 CFDA device classification 44
6.1.6 INDIA 45
6.1.7 AUSTRALIA 46
6.1.7.1 ATG device classification 46
6.2 PRODUCT PIPELINE ASSESSMENT 47
6.2.1 INTRODUCTION 47
6.2.2 CLINICAL TRIALS FOR MEDICAL ROBOTS 47
6.2.3 UPCOMING PRODUCT LAUNCHES 50

7 GLOBAL MEDICAL ROBOTS MARKET, BY PRODUCT 51
7.1 INTRODUCTION 52
7.2 INSTRUMENTS AND ACCESSORIES 54
7.3 MEDICAL ROBOTIC SYSTEMS 55
7.3.1 SURGICAL ROBOTS 57
7.3.1.1 Laparoscopy robotic systems 59
7.3.1.2 Orthopedic robotic systems 59
7.3.1.3 Neurosurgical robotic systems 60
7.3.1.4 Steerable robotic catheters 60
7.3.2 REHABILITATION ROBOTIC SYSTEMS 60
7.3.2.1 Therapeutic robotic systems 62
7.3.2.2 Assistive robotic systems 63
7.3.2.3 Prosthetic robotic systems 63
7.3.2.4 Orthotic robotic systems 64
7.3.2.5 Exoskeleton robotic systems 64
7.3.3 NONINVASIVE RADIOSURGERY ROBOTIC SYSTEMS 64
7.3.4 HOSPITAL AND PHARMACY ROBOTIC SYSTEMS 66
7.3.4.1 Pharmacy robotic systems 68
7.3.4.2 IV robotic systems 68
7.3.4.3 Telemedicine robots 68
7.3.5 OTHER ROBOTIC SYSTEMS 69

8 MEDICAL ROBOTS MARKET, BY APPLICATION 70
8.1 INTRODUCTION 71
8.2 LAPAROSCOPY 72
8.3 ORTHOPEDICS 73
8.4 NEUROLOGY 73
8.5 SPECIAL EDUCATION 75
8.6 OTHER APPLICATIONS 76

9 MEDICAL ROBOTS MARKET, BY REGION 77
9.1 INTRODUCTION 78
9.2 NORTH AMERICA 81
9.2.1 U.S. 83
9.2.1.1 Advent of telemedicine robots to address the shortage of healthcare professionals in the U.S. 83
9.2.1.2 Increasing medical robot purchases by hospitals backed by the demand for minimally invasive surgeries 83
9.2.1.3 Availability of significant funding from the NIH 84
9.2.1.4 Funding by the U.S. Department of Defense 84
9.2.1.5 Growing FDA approvals 85
9.2.1.6 Grants from NSF to propel research activities 85
9.2.1.7 Rising venture capital investments 86
9.2.2 CANADA 87
9.2.2.1 Use of robots in pediatric care 87
9.2.2.2 Government support 88
9.3 EUROPE 90
9.3.1 EU5 92
9.3.1.1 Favorable reimbursement scenario in Germany 92
9.3.1.2 Presence of a large pool of end users in Germany 92
9.3.1.3 Development of affordable robotic prosthesis in France 92
9.3.1.4 Growing robotics market in France 93
9.3.1.5 Adoption of pharmacy robots in the U.K. 93
 
9.3.2 ROE 94
9.3.2.1 Introduction of mind-controlled prosthetic robotic limbs in Austria 94
9.3.2.2 Continuous support from governments 94
9.4 ASIA-PACIFIC 96
9.4.1 NURSING ROBOTS TO ADDRESS THE SHORTAGE OF CARE WORKERS IN JAPAN, SOUTH KOREA, AND HONG KONG 97
9.4.2 GROWTH IN THE NUMBER OF APPROVALS FOR USE OF MEDICAL ROBOTS IN JAPAN 97
9.4.3 RISING PREVALENCE OF CANCER IN CHINA 97
9.4.4 FOREIGN PARTNERSHIPS AND GROWING START-UP COMPANIES IN CHINA 98
9.4.5 GROWING ROBOTIC PROCEDURES BACKED BY RISING NUMBER OF HOSPITAL BEDS IN INDIA 98
9.4.6 RISING ADOPTION OF MEDICAL ROBOTS IN ASIA 98
9.4.7 FUNDING AND COLLABORATIONS 99
9.4.8 TRAINING PROGRAMS IN AUSTRALIA 99
9.5 REST OF THE WORLD (ROW) 101
9.5.1 INTRODUCTION OF TELEMEDICINE ROBOTS IN AFRICA 101
9.5.2 INTERNATIONAL WORKSHOPS ON ROBOTICS IN BRAZIL 102
9.5.3 DOMESTIC MANUFACTURING OF SURGICAL ROBOTS IN IRAN 102

10 COMPETITIVE LANDSCAPE 104
10.1 OVERVIEW 104
10.2 MARKET SHARE ANALYSIS 105
10.3 COMPETITIVE SITUATION AND TRENDS 106
10.3.1 MARKETING AND PROMOTIONAL ACTIVITIES 107
10.3.2 AGREEMENTS, COLLABORATIONS, JOINT VENTURES, AND PARTNERSHIPS 107
10.3.3 ACQUISITIONS 108
10.3.4 PRODUCT LAUNCHES 109
10.3.5 EXPANSIONS 109
10.3.6 OTHER STRATEGIES 110

11 COMPANY PROFILES 111
11.1 INTRODUCTION 111
(Overview, Financials, Products & Services, Strategy, and Developments)*
11.2 INTUITIVE SURGICAL, INC. 112
11.3 STRYKER CORPORATION 114
11.4 HOCOMA AG 116
11.5 MAZOR ROBOTICS LTD. 118
11.6 HANSEN MEDICAL, INC. (A WHOLLY OWNED SUBSIDIARY OF AURIS SURGICAL ROBOTICS) 120
11.7 ACCURAY INCORPORATED 122
11.8 OMNICELL, INC. 124
11.9 ARXIUM 126
11.10 EKSO BIONICS HOLDINGS, INC. 128
11.11 KIRBY LESTER LLC 130
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted companies.

12 APPENDIX 131
12.1 DISCUSSION GUIDE 131
12.2 OTHER DEVELOPMENTS 137
12.2.1 INTUITIVE SURGICAL, INC. 137
12.2.2 HOCOMA AG 137
12.2.3 MAZOR ROBOTICS LTD. 137
12.2.4 HANSEN MEDICAL, INC. (A WHOLLY OWNED SUBSIDIARY OF AURIS SURGICAL ROBOTICS) 138
12.2.5 ACCURAY INCORPORATED 139
12.2.6 OMNICELL, INC. 139
12.2.7 ARXIUM 140
12.2.8 EKSO BIONICS HOLDINGS, INC. 140
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 142
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 144
12.5 AVAILABLE CUSTOMIZATIONS 145
12.6 RELATED REPORTS 145
12.7 AUTHOR DETAILS 146